This is a preview of subscription content, log in via an institution to check access.
Reference
Pease C, et al. Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting. BMJ Open : 20 May 2021. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2020-047514
Rights and permissions
About this article
Cite this article
Weekly rifapentine + isoniazid for latent TB infections saves costs in Nunavut, Canada. PharmacoEcon Outcomes News 879, 32 (2021). https://doi.org/10.1007/s40274-021-7755-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7755-3